Page last updated: 2024-08-25

oxazolidin-2-one and Infectious Skin Diseases

oxazolidin-2-one has been researched along with Infectious Skin Diseases in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (70.59)29.6817
2010's4 (23.53)24.3611
2020's1 (5.88)2.80

Authors

AuthorsStudies
Li, H; Li, Z; Lyu, C; Shen, J; Wang, X; Zhang, L1
Bouza, E; Burillo, A; Muñoz, P1
Corey, GR; Das, AF; De Anda, C; Fang, E; Lodise, TP; Prokocimer, P; Shorr, AF1
Concia, E; Falcone, M; Giusti, M; Mazzone, A; Santini, C; Stefani, S; Violi, F1
Esposito, S; Leone, S; Noviello, S1
Besnier, JM; De Cock, E; Dupon, M; Duttagupta, S; Guery, B; Levrat, F; Sorensen, S1
Cuervo, J; Gil-Parrado, S; Grau, S; Rebollo, P1
Bruss, J; Fleishaker, D; Hilty, M; Naberhuis-Stehouwer, S; Tregnaghi, M; Wible, K1
Katta, R; Metry, D1
Scheinfeld, NS; Weinberg, JM1
Bodmann, KF1
Choi, SH; Gonzalez, G; Ochoa-Felix, EY; Tijerina, R; Vera-Cabrera, L; Welsh, O1
Polk, HC; Sharpe, JN; Shively, EH1
Itani, KM; Liu, LZ; McKinnon, PS; Sorensen, SV1
Peppard, WJ; Weigelt, JA1
Wilson, P1

Reviews

8 review(s) available for oxazolidin-2-one and Infectious Skin Diseases

ArticleYear
The role of tedizolid in skin and soft tissue infections.
    Current opinion in infectious diseases, 2018, Volume: 31, Issue:2

    Topics: Anti-Bacterial Agents; Drug-Related Side Effects and Adverse Reactions; Gram-Positive Bacterial Infections; Humans; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Tetrazoles; Treatment Outcome

2018
Acute bacterial skin and skin structure infections in internal medicine wards: old and new drugs.
    Internal and emergency medicine, 2016, Volume: 11, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Ceftaroline; Cephalosporins; Daptomycin; Female; Fluoroquinolones; Glycopeptides; Hospitalization; Humans; Iatrogenic Disease; Internal Medicine; Linezolid; Lipoglycopeptides; Male; Minocycline; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Teicoplanin; Tigecycline; Vancomycin

2016
[Skin and soft tissue infections: current therapeutic options].
    Le infezioni in medicina, 2008, Volume: 16, Issue:2

    Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Daptomycin; Humans; Linezolid; Methicillin Resistance; Middle Aged; Minocycline; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Tigecycline; Time Factors; Treatment Outcome

2008
New and emerging pediatric infections.
    Dermatologic clinics, 2003, Volume: 21, Issue:2

    Topics: Acetamides; Child; Drug Resistance, Multiple; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Skin Diseases, Infectious; Staphylococcal Infections

2003
Cutaneous infections in the elderly: diagnosis and management.
    Dermatologic therapy, 2003, Volume: 16, Issue:3

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Anti-Bacterial Agents; Antidepressive Agents, Tricyclic; Antiviral Agents; Famciclovir; Herpes Zoster; Humans; Itraconazole; Linezolid; Onychomycosis; Oxazolidinones; Skin Diseases, Infectious; Virginiamycin

2003
[Action in nosocomial pneumonia and severe skin and soft tissue infections. Linezolid in treatment].
    Pharmazie in unserer Zeit, 2004, Volume: 33, Issue:1

    Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Pneumonia, Bacterial; Skin Diseases, Infectious; Soft Tissue Infections

2004
Role of linezolid in the treatment of complicated skin and soft tissue infections.
    Expert review of anti-infective therapy, 2006, Volume: 4, Issue:3

    Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Bacterial; Humans; Linezolid; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections

2006
Linezolid: a new antibiotic for gram-positive infections.
    Hospital medicine (London, England : 1998), 2001, Volume: 62, Issue:11

    Topics: Acetamides; Anti-Infective Agents; Drug Costs; Drug Resistance, Bacterial; Gram-Positive Bacterial Infections; Humans; Linezolid; Oxazolidinones; Respiratory Tract Infections; Skin Diseases, Infectious; Soft Tissue Infections

2001

Trials

4 trial(s) available for oxazolidin-2-one and Infectious Skin Diseases

ArticleYear
Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Acetamides; Anti-Bacterial Agents; Double-Blind Method; Female; Humans; Linezolid; Male; Oxazolidinones; Skin Diseases, Bacterial; Skin Diseases, Infectious; Staphylococcal Skin Infections; Tetrazoles

2015
Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
    The Pediatric infectious disease journal, 2003, Volume: 22, Issue:4

    Topics: Acetamides; Administration, Oral; Adolescent; Cefadroxil; Child; Child, Preschool; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Oxazolidinones; Probability; Prospective Studies; Reference Values; Risk Assessment; Single-Blind Method; Skin Diseases, Infectious; Treatment Outcome

2003
Clinical and economic outcomes of oral linezolid versus intravenous vancomycin in the treatment of MRSA-complicated, lower-extremity skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus.
    American journal of surgery, 2005, Volume: 189, Issue:4

    Topics: Acetamides; Administration, Oral; Adult; Aged; Cost-Benefit Analysis; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Linezolid; Lower Extremity; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Probability; Reference Values; Severity of Illness Index; Single-Blind Method; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin

2005
Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections.
    The Annals of pharmacotherapy, 2006, Volume: 40, Issue:6

    Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Clinical Trials as Topic; Cost-Benefit Analysis; Delivery of Health Care; Drug Costs; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Linezolid; Male; Methicillin Resistance; Middle Aged; Oxazolidinones; Prospective Studies; Regression Analysis; Skin Diseases, Infectious; Streptococcal Infections; Treatment Outcome; Vancomycin

2006

Other Studies

5 other study(ies) available for oxazolidin-2-one and Infectious Skin Diseases

ArticleYear
Clinical efficacy of psychiatric nursing-based vancomycin in the treatment of Staphylococcus aureus infectious skin diseases.
    Pakistan journal of pharmaceutical sciences, 2023, Volume: 36, Issue:2(Special)

    Topics: Acetamides; Anti-Bacterial Agents; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Psychiatric Nursing; Retrospective Studies; Skin Diseases, Infectious; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin

2023
Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France.
    Medecine et maladies infectieuses, 2009, Volume: 39, Issue:5

    Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Decision Trees; Drug Monitoring; France; Gram-Positive Bacterial Infections; Humans; Inpatients; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Skin Diseases, Infectious; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections

2009
[Pharmacoeconomic assessment of daptomycin as first-line therapy for bacteraemia and complicated skin and skin structure infections caused by gram-positive pathogens in Spain].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2011, Volume: 24, Issue:3

    Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cost-Benefit Analysis; Daptomycin; Data Interpretation, Statistical; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Hospitals; Humans; Linezolid; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Oxazolidinones; Salvage Therapy; Skin Diseases, Infectious; Spain; Treatment Failure; Vancomycin; Young Adult

2011
In vitro activities of new quinolones and oxazolidinones against Actinomadura madurae.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:3

    Topics: Anti-Infective Agents; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxazolidinones; Quinolones; Skin Diseases, Infectious

2004
Two new drugs join the war on superbugs.
    Mayo Clinic health letter (English ed.), 2000, Volume: 18, Issue:10

    Topics: Acetamides; Anti-Infective Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Linezolid; Oxazolidinones; Pneumonia; Skin Diseases, Infectious; Vancomycin Resistance; Virginiamycin

2000